NCT06734260View on ClinicalTrials.gov

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection

PHASE3RecruitingINTERVENTIONAL
Enrollment

567

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

November 10, 2025

Study Completion Date

November 10, 2025

Conditions
Helicobacter Pylori Eradication Rate
Interventions
DRUG

Keverprazan Hydrochloride tablets + high dose amoxicillin

Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 14 day

DRUG

Keverprazan Hydrochloride tablets + low dose amoxicillin

Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 2 times/day, oral, for 14 day

DRUG

Keverprazan Hydrochloride tablets + high dose amoxicillin（H-KA-10d）

Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 10 day

Trial Locations (1)

518033

RECRUITING

Eighth Affiliated Hospital,Sun Yet-san University, Shenzhen

All Listed Sponsors
lead

Eighth Affiliated Hospital, Sun Yat-sen University

OTHER